Total Visits

Views
Clinical experience with the integrase inhibitors Dolutegravir and Elvitegravir in HIV-infected patients: efficacy, safety and tolerance220

Total Visits Per Month

August 2023September 2023October 2023November 2023December 2023January 2024February 2024March 2024April 2024May 2024June 2024
Clinical experience with the integrase inhibitors Dolutegravir and Elvitegravir in HIV-infected patients: efficacy, safety and tolerance000311702221

File Visits

Views
Cid_Clinical.pdf271

Top country views

Views
United States128
Spain21
Germany20
Ireland6
Ukraine6
Sweden5
France4
Taiwan4
Vietnam3
South Korea2

Top cities views

Views
Ashburn44
Fairfield29
A Coruña15
Cambridge9
Dublin5
Jacksonville5
Louisville5
Falls Church4
Mountain View4
Seattle4